There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape analysis focusing on issued U.S. patents and pending applications. We found several geographical clusters and a trend in the development of the technology away from the use of genetic transforming factors. A brief report on our analysis was recently published on line – “Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis.”
This report is interesting not only from a patent analyst’s perspective of tracking the evolution of IP in a particular technology, but also because it shows a clear evolution of the technology and processes for achieving the same result using different techniques.
Related Insights
March 31, 2020
Blogs
Utilization of Natural Phenomenon Found Patent Eligible
In Illumina, Inc. v. Ariosa Diagnositcs, Inc., (Fed. Cir. Slip Op. 2019-1419, March 17, 2020) the Federal Circuit held that process claims that exploit the discovered size differences between fetal and maternal DNA in serum or plasma are patent eligible.
September 11, 2015
Blogs
Breaking Through to Business Solutions for Personalized Medicine: A Thought-Provoking, Can’t-Miss Industry Event
Just as with patient treatments, one size does not fit all when it comes to companies involved in personalized medicine.
August 3, 2015
Blogs
Inventorship, Ownership Issues Cause Dismissal of Suit
On July 22, 2015, the U.S. District Court for the District of Maryland dismissed a long standing patent infringement suit brought by StemCells, Inc. against Neuralstem, Inc., on the ground that all those with an ownership interest in the patents-in-suit did not voluntarily join as plaintiffs in the action.